Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Vasospasm and stroke attributable to ephedra-free xenadrine: case report.

Holmes RO Jr, Tavee J.

Mil Med. 2008 Jul;173(7):708-10.

PMID:
18700609
2.

Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine.

Bouchard NC, Howland MA, Greller HA, Hoffman RS, Nelson LS.

Mayo Clin Proc. 2005 Apr;80(4):541-5.

PMID:
15819293
3.

Coronary thrombosis related to use of Xenadrine RFA.

Sachdeva R, Sivasankaran S, Fishman RF, Zarich SW, McPherson CA.

Tex Heart Inst J. 2005;32(1):74-7.

4.

Ischemic stroke after using over the counter products containing ephedra.

Chen C, Biller J, Willing SJ, Lopez AM.

J Neurol Sci. 2004 Jan 15;217(1):55-60.

PMID:
14675610
5.

More evidence supporting the ban of ephedra dietary supplements.

Chavez ML.

Ann Pharmacother. 2004 May;38(5):895-7. Epub 2004 Mar 25. No abstract available.

PMID:
15044656
6.

Use of Ephedra-containing products and risk for hemorrhagic stroke.

Morgenstern LB, Viscoli CM, Kernan WN, Brass LM, Broderick JP, Feldmann E, Wilterdink JL, Brott T, Horwitz RI.

Neurology. 2003 Jan 14;60(1):132-5. Erratum in: Neurology. 2003 Mar 25;60(6):1055.

PMID:
12525737
7.

Hypertensive Urgency Associated With Xenadrine EFX Use.

Moaddeb J, Tofade TS, Bevins MB.

J Pharm Pract. 2011 Jun 6. [Epub ahead of print]

PMID:
21676849
8.
9.

Hemodynamic effects of ephedra-free weight-loss supplements in humans.

Haller CA, Benowitz NL, Jacob P 3rd.

Am J Med. 2005 Sep;118(9):998-1003.

PMID:
16164886
10.

Ephedra-free is not danger-free.

Marcus DM, Grollman AP.

Science. 2003 Sep 19;301(5640):1669-71; author reply 1669-71. No abstract available.

PMID:
14500960
11.

The relative safety of ephedra compared with other herbal products.

Kalman DS, Antonio J, Kreider RB.

Ann Intern Med. 2003 Jun 17;138(12):1006; author reply 1006-7. No abstract available.

PMID:
12809464
12.

Ergogenic aids: an update on ephedra.

Keisler BD, Hosey RG.

Curr Sports Med Rep. 2005 Aug;4(4):231-5. Review.

PMID:
16004835
13.

Vasospasm-induced stroke in a varsity athlete secondary to ephedrine ingestion.

Foxford RJ, Sahlas DJ, Wingfield KA.

Clin J Sport Med. 2003 May;13(3):183-5. No abstract available.

PMID:
12792214
14.

Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial.

McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM.

JAMA. 2004 Jan 14;291(2):216-21.

PMID:
14722148
15.

Electrocardiographic effects of a dietary supplement containing ephedra and caffeine.

Milic M, Rizos D, Ziegler MG.

JAMA. 2005 Sep 28;294(12):1487; author reply 1487-8. No abstract available.

PMID:
16189358
16.

[Case of intractable ventricula fibrillation by a multicomponent dietary supplement containing ephedra and caffeine overdose].

Takeuchi S, Homma M, Inoue J, Kato H, Murata K, Ogasawara T.

Chudoku Kenkyu. 2007 Jul;20(3):269-71. Japanese.

PMID:
17784561
17.

Ephedra-associated cardiomyopathy.

Naik SD, Freudenberger RS.

Ann Pharmacother. 2004 Mar;38(3):400-3. Epub 2004 Jan 23.

PMID:
14742827
18.

STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature.

Thomas JE, Munir JA, McIntyre PZ, Ferguson MA.

Tex Heart Inst J. 2009;36(6):586-90. Review.

19.

Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.

Nykamp DL, Fackih MN, Compton AL.

Ann Pharmacother. 2004 May;38(5):812-6. Epub 2004 Mar 16.

PMID:
15026566
20.

Adverse events associated with supplements containing ephedra alkaloids.

Geiger JD.

Clin J Sport Med. 2002 Jul;12(4):263. No abstract available.

PMID:
12150162
Items per page

Supplemental Content

Write to the Help Desk